학술논문
Outcomes After Retreatment With Inotuzumab Ozogamicin for Relapsed/Refractory Philadelphia Chromosome–Negative B-Cell Acute Lymphoblastic Leukemia
Document Type
Academic Journal
Source
JCO Precision Oncology. Jan 01, 2022 6:e2200353-e2200353
Subject
Language
English
ISSN
2473-4284